Suppression of Alzheimer's disease-related phenotypes by expression of heat shock protein 70 in mice

Tatsuya Hoshino, Naoya Murao, Takushi Namba, Masaya Takehara, Hiroaki Adachi, Masahisa Katsuno, Gen Sobue, Takahide Matsushima, Toshiharu Suzuki, Tohru Mizushima

Research output: Contribution to journalArticle

100 Citations (Scopus)

Abstract

Amyloid-β peptide (Aβ) plays an important role in the pathogenesis of Alzheimer's disease (AD). A β is generated by proteolysis of β-amyloid precursor protein (APP) and is cleared by enzyme-mediated degradation and phagocytosis by microglia and astrocytes. Some cytokines, such as TGF-β1, stimulate this phagocytosis. In contrast, cellular up regulation of HSP70 expression provides cytoprotection against Aβ. HSP70 activity in relation to inhibition of Aβ oligomerization and stimulation of Aβ phagocytosis has also been reported. Although these in vitro results suggest that stimulating the expression ofHSP70could prove effective in the treatment of AD, there is a lack of in vivo evidence supporting this notion. In this study, we address this issue, using transgenic mice expressing HSP70 and/or a mutant form of APP (APPsw). Transgenic mice expressing APPsw showed less of an apparent cognitive deficit when they were crossed with transgenic mice expressing HSP70. Transgenic mice expressing HSP70 also displayed lower levels of Aβ, Aβ plaque deposition, and neuronal and synaptic loss than control mice. Immuno blotting experiments and direct measurement of β- and γ-secretase activity suggested that over expression of HSP70 does not affect the production Aβ. In contrast, HSP70 over expression did lead to up regulation of the expression of Aβ-degrading enzyme and TGF-β1 both in vivo and in vitro. These results suggest that over expression of HSP70 in mice suppresses not only the pathological but also the functional phenotypes of AD. This study provides the first in vivo evidence confirming the potential therapeutic benefit of HSP70 for the prevention or treatment of AD.

Original languageEnglish
Pages (from-to)5225-5234
Number of pages10
JournalJournal of Neuroscience
Volume31
Issue number14
DOIs
Publication statusPublished - 2011 Apr 6
Externally publishedYes

Fingerprint

HSP70 Heat-Shock Proteins
Transgenic Mice
Alzheimer Disease
Phagocytosis
Phenotype
Amyloid beta-Protein Precursor
Up-Regulation
Amyloid Precursor Protein Secretases
Cytoprotection
Microglia
Enzymes
Amyloid
Astrocytes
Proteolysis
Cytokines
In Vitro Techniques
Therapeutics

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Hoshino, T., Murao, N., Namba, T., Takehara, M., Adachi, H., Katsuno, M., ... Mizushima, T. (2011). Suppression of Alzheimer's disease-related phenotypes by expression of heat shock protein 70 in mice. Journal of Neuroscience, 31(14), 5225-5234. https://doi.org/10.1523/JNEUROSCI.5478-10.2011

Suppression of Alzheimer's disease-related phenotypes by expression of heat shock protein 70 in mice. / Hoshino, Tatsuya; Murao, Naoya; Namba, Takushi; Takehara, Masaya; Adachi, Hiroaki; Katsuno, Masahisa; Sobue, Gen; Matsushima, Takahide; Suzuki, Toshiharu; Mizushima, Tohru.

In: Journal of Neuroscience, Vol. 31, No. 14, 06.04.2011, p. 5225-5234.

Research output: Contribution to journalArticle

Hoshino, T, Murao, N, Namba, T, Takehara, M, Adachi, H, Katsuno, M, Sobue, G, Matsushima, T, Suzuki, T & Mizushima, T 2011, 'Suppression of Alzheimer's disease-related phenotypes by expression of heat shock protein 70 in mice', Journal of Neuroscience, vol. 31, no. 14, pp. 5225-5234. https://doi.org/10.1523/JNEUROSCI.5478-10.2011
Hoshino, Tatsuya ; Murao, Naoya ; Namba, Takushi ; Takehara, Masaya ; Adachi, Hiroaki ; Katsuno, Masahisa ; Sobue, Gen ; Matsushima, Takahide ; Suzuki, Toshiharu ; Mizushima, Tohru. / Suppression of Alzheimer's disease-related phenotypes by expression of heat shock protein 70 in mice. In: Journal of Neuroscience. 2011 ; Vol. 31, No. 14. pp. 5225-5234.
@article{188e1a1037754913841b04d98c8d9809,
title = "Suppression of Alzheimer's disease-related phenotypes by expression of heat shock protein 70 in mice",
abstract = "Amyloid-β peptide (Aβ) plays an important role in the pathogenesis of Alzheimer's disease (AD). A β is generated by proteolysis of β-amyloid precursor protein (APP) and is cleared by enzyme-mediated degradation and phagocytosis by microglia and astrocytes. Some cytokines, such as TGF-β1, stimulate this phagocytosis. In contrast, cellular up regulation of HSP70 expression provides cytoprotection against Aβ. HSP70 activity in relation to inhibition of Aβ oligomerization and stimulation of Aβ phagocytosis has also been reported. Although these in vitro results suggest that stimulating the expression ofHSP70could prove effective in the treatment of AD, there is a lack of in vivo evidence supporting this notion. In this study, we address this issue, using transgenic mice expressing HSP70 and/or a mutant form of APP (APPsw). Transgenic mice expressing APPsw showed less of an apparent cognitive deficit when they were crossed with transgenic mice expressing HSP70. Transgenic mice expressing HSP70 also displayed lower levels of Aβ, Aβ plaque deposition, and neuronal and synaptic loss than control mice. Immuno blotting experiments and direct measurement of β- and γ-secretase activity suggested that over expression of HSP70 does not affect the production Aβ. In contrast, HSP70 over expression did lead to up regulation of the expression of Aβ-degrading enzyme and TGF-β1 both in vivo and in vitro. These results suggest that over expression of HSP70 in mice suppresses not only the pathological but also the functional phenotypes of AD. This study provides the first in vivo evidence confirming the potential therapeutic benefit of HSP70 for the prevention or treatment of AD.",
author = "Tatsuya Hoshino and Naoya Murao and Takushi Namba and Masaya Takehara and Hiroaki Adachi and Masahisa Katsuno and Gen Sobue and Takahide Matsushima and Toshiharu Suzuki and Tohru Mizushima",
year = "2011",
month = "4",
day = "6",
doi = "10.1523/JNEUROSCI.5478-10.2011",
language = "English",
volume = "31",
pages = "5225--5234",
journal = "Journal of Neuroscience",
issn = "0270-6474",
publisher = "Society for Neuroscience",
number = "14",

}

TY - JOUR

T1 - Suppression of Alzheimer's disease-related phenotypes by expression of heat shock protein 70 in mice

AU - Hoshino, Tatsuya

AU - Murao, Naoya

AU - Namba, Takushi

AU - Takehara, Masaya

AU - Adachi, Hiroaki

AU - Katsuno, Masahisa

AU - Sobue, Gen

AU - Matsushima, Takahide

AU - Suzuki, Toshiharu

AU - Mizushima, Tohru

PY - 2011/4/6

Y1 - 2011/4/6

N2 - Amyloid-β peptide (Aβ) plays an important role in the pathogenesis of Alzheimer's disease (AD). A β is generated by proteolysis of β-amyloid precursor protein (APP) and is cleared by enzyme-mediated degradation and phagocytosis by microglia and astrocytes. Some cytokines, such as TGF-β1, stimulate this phagocytosis. In contrast, cellular up regulation of HSP70 expression provides cytoprotection against Aβ. HSP70 activity in relation to inhibition of Aβ oligomerization and stimulation of Aβ phagocytosis has also been reported. Although these in vitro results suggest that stimulating the expression ofHSP70could prove effective in the treatment of AD, there is a lack of in vivo evidence supporting this notion. In this study, we address this issue, using transgenic mice expressing HSP70 and/or a mutant form of APP (APPsw). Transgenic mice expressing APPsw showed less of an apparent cognitive deficit when they were crossed with transgenic mice expressing HSP70. Transgenic mice expressing HSP70 also displayed lower levels of Aβ, Aβ plaque deposition, and neuronal and synaptic loss than control mice. Immuno blotting experiments and direct measurement of β- and γ-secretase activity suggested that over expression of HSP70 does not affect the production Aβ. In contrast, HSP70 over expression did lead to up regulation of the expression of Aβ-degrading enzyme and TGF-β1 both in vivo and in vitro. These results suggest that over expression of HSP70 in mice suppresses not only the pathological but also the functional phenotypes of AD. This study provides the first in vivo evidence confirming the potential therapeutic benefit of HSP70 for the prevention or treatment of AD.

AB - Amyloid-β peptide (Aβ) plays an important role in the pathogenesis of Alzheimer's disease (AD). A β is generated by proteolysis of β-amyloid precursor protein (APP) and is cleared by enzyme-mediated degradation and phagocytosis by microglia and astrocytes. Some cytokines, such as TGF-β1, stimulate this phagocytosis. In contrast, cellular up regulation of HSP70 expression provides cytoprotection against Aβ. HSP70 activity in relation to inhibition of Aβ oligomerization and stimulation of Aβ phagocytosis has also been reported. Although these in vitro results suggest that stimulating the expression ofHSP70could prove effective in the treatment of AD, there is a lack of in vivo evidence supporting this notion. In this study, we address this issue, using transgenic mice expressing HSP70 and/or a mutant form of APP (APPsw). Transgenic mice expressing APPsw showed less of an apparent cognitive deficit when they were crossed with transgenic mice expressing HSP70. Transgenic mice expressing HSP70 also displayed lower levels of Aβ, Aβ plaque deposition, and neuronal and synaptic loss than control mice. Immuno blotting experiments and direct measurement of β- and γ-secretase activity suggested that over expression of HSP70 does not affect the production Aβ. In contrast, HSP70 over expression did lead to up regulation of the expression of Aβ-degrading enzyme and TGF-β1 both in vivo and in vitro. These results suggest that over expression of HSP70 in mice suppresses not only the pathological but also the functional phenotypes of AD. This study provides the first in vivo evidence confirming the potential therapeutic benefit of HSP70 for the prevention or treatment of AD.

UR - http://www.scopus.com/inward/record.url?scp=79955415881&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79955415881&partnerID=8YFLogxK

U2 - 10.1523/JNEUROSCI.5478-10.2011

DO - 10.1523/JNEUROSCI.5478-10.2011

M3 - Article

C2 - 21471357

AN - SCOPUS:79955415881

VL - 31

SP - 5225

EP - 5234

JO - Journal of Neuroscience

JF - Journal of Neuroscience

SN - 0270-6474

IS - 14

ER -